Clinical Outcomes has evidence across 10 diabetes-related interventions, with strongest support for Diabetes Self-Management Education and Support (DSMES) Programs, SGLT2 Inhibitors and GLP-1 Receptor Agonists.
Evidence Intelligence™
Every evidence topic is generated from structured relationships across diabetes research, including topics, interventions, outcomes, and individual studies.
| Rank | Intervention group | Outcome group | EvidenceScore™ | ImpactScore™ | Consistency | Studies | Effectiveness | Action |
|---|---|---|---|---|---|---|---|---|
| #1 | Diabetes Self-Management Education and Support (DSMES) Programs | Diabetes Incidence and Prevention | 85/100Strong | 78/100Positive | 80/100consistent | 5 | moderate_positive | Explore evidence |
| #2 | SGLT2 Inhibitors | Kidney Function | 85/100Strong | 71/100Positive | 80/100consistent | 12 | moderate_positive | Explore evidence |
| #3 | GLP-1 Receptor Agonists | Cardiovascular Outcomes | 83/100Strong | 64/100Slightly Positive | 75/100consistent | 13 | weak_positive | Explore evidence |
| #4 | Insulin Delivery Systems | Sleep Outcomes | 83/100Strong | 55/100Slightly Positive | 60/100generally_consistent | 5 | weak_positive | Explore evidence |
| #5 | Diabetes Self-Management Education and Support (DSMES) Programs | Cardiovascular Outcomes | Strong | 88/100Very Positive | 67/100generally_consistent | 4 | strong_positive | Explore evidence |
| #6 | SGLT2 Inhibitors | Cardiovascular Outcomes | Strong | 75/100Positive | 35/100mixed | 4 | moderate_positive | Explore evidence |
| #7 | DPP-4 Inhibitors | Kidney Function | Strong | 83/100Positive | 100/100consistent | 3 | moderate_positive | Explore evidence |
| #8 | Glycemic Control Treatments | Cardiovascular Outcomes | Strong | 67/100Slightly Positive | 35/100mixed | 3 | weak_positive | Explore evidence |
| #9 | Insulin Therapies | Kidney Function | Strong | 58/100Slightly Positive | 35/100mixed | 3 | weak_positive | Explore evidence |
| #10 | Metformin Therapies | Diabetes Incidence and Prevention | Strong | 83/100Positive | 67/100generally_consistent | 3 | moderate_positive | Explore evidence |
Diabetes Self-Management Education and Support (DSMES) Programs → Diabetes Incidence and Prevention
SGLT2 Inhibitors → Kidney Function
GLP-1 Receptor Agonists → Cardiovascular Outcomes
Insulin Delivery Systems → Sleep Outcomes
Diabetes Self-Management Education and Support (DSMES) Programs → Cardiovascular Outcomes
SGLT2 Inhibitors → Cardiovascular Outcomes
DPP-4 Inhibitors → Kidney Function
Glycemic Control Treatments → Cardiovascular Outcomes
Insulin Therapies → Kidney Function
Metformin Therapies → Diabetes Incidence and Prevention
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
Non-surgical periodontal treatment have the strongest available evidence signals for Clinical Outcomes.
ConsistencyScore™: Results are consistent across studies.
Ranked evidence signals
Non-surgical periodontal treatment
EvidenceScore™ Strong | EvidenceScore™ 84.3 | moderate positive | ConsistencyScore™ Generally Consistent | 15 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Lifestyle intervention for prediabetes, Liraglutide, and Semaglutide are among the most studied areas in relation to Clinical Outcomes.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Lifestyle intervention for prediabetes
EvidenceScore™ Strong | EvidenceScore™ 87.9 | moderate positive | ConsistencyScore™ Mixed | 23 studies
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 83.2 | strong positive | ConsistencyScore™ Generally Consistent | 20 studies
Liraglutide
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 14 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Results are mixed or unclear for Aerobic exercise, Complex lifestyle intervention, and Continuous glucose monitoring in relation to Clinical Outcomes.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Ranked evidence signals
Lifestyle intervention for prediabetes
EvidenceScore™ Strong | EvidenceScore™ 87.9 | moderate positive | ConsistencyScore™ Mixed | 10 studies
SRP + OHI
EvidenceScore™ Strong | EvidenceScore™ 79.0 | moderate positive | ConsistencyScore™ Mixed | 4 studies
Semaglutide
EvidenceScore™ Strong | EvidenceScore™ 79.0 | weak negative | ConsistencyScore™ Mixed | 10 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
1 g omega-3 fatty acids daily need more research in relation to Clinical Outcomes.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
1 g omega-3 fatty acids daily
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Lifestyle intervention for prediabetes and Non-surgical periodontal treatment have available evidence for Clinical Outcomes, but the comparison requires review of the underlying studies.
ConsistencyScore™: Results are mixed and should be interpreted cautiously.
Ranked evidence signals
Lifestyle intervention for prediabetes
EvidenceScore™ Strong | EvidenceScore™ 87.9 | moderate positive | ConsistencyScore™ Mixed | 8 studies
Non-surgical periodontal treatment
EvidenceScore™ Strong | EvidenceScore™ 84.3 | moderate positive | ConsistencyScore™ Generally Consistent | 13 studies
Why this answer: This answer is cautious because the available studies report mixed findings.
Intervention categories most commonly studied for clinical outcomes outcomes.
Evidence related to GLP-1 receptor agonist therapies in diabetes studies.
Evidence related to SGLT2 inhibitor therapies in diabetes studies.
Evidence related to insulin therapies in diabetes studies.
Evidence related to diabetes self-management education and support programs in diabetes studies.
Evidence related to aerobic exercise interventions in diabetes studies.
Evidence related to DPP-4 inhibitor therapies in diabetes studies.
Each bubble represents an evidence relationship. Position shows effectiveness and EvidenceScoreâ„¢; size reflects study volume.
Evidence Workspace
Save evidence topics and organize the research that matters to you.
